Medicare Enrolled

Dr. Ramesh Gopalaswamy, MD

Neurology · Plantation, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
260 SW 84TH AVE STE C, Plantation, FL 33324
9543613116
In practice since 2006 (19 years)
NPI: 1437167129 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gopalaswamy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gopalaswamy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gopalaswamy

Dr. Ramesh Gopalaswamy is a neurology specialist in Plantation, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gopalaswamy performed 1,258 Medicare services across 932 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gopalaswamy received a total of $29,085 from 80 pharmaceutical and/or device companies across 1313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gopalaswamy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in FL $29,085 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 97455 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
1,258
Medicare services
Top 26% in FL for neurology
932
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~66 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 389 $96 $562
Annual depression screening 158 $19 $77
New patient office visit (45-59 min) 117 $128 $730
Initial hospital admission, high complexity 109 $147 $870
Office visit, established patient, complex (40-54 min) 87 $145 $788
Hospital follow-up visit, moderate complexity 64 $66 $312
Comprehensive eye exam, established patient 57 $95 $532
Needle measurement of electrical activity in arm or leg muscles, complete study 56 $141 $706
Exam to measure eye deviation and range of motion 52 $49 $265
Nerve conduction, 9-10 studies 43 $170 $960
Measurement of brain wave activity (eeg), awake and drowsy 31 $309 $1,599
Initial hospital admission, moderate complexity 31 $113 $596
Comprehensive eye exam, new patient 26 $111 $629
Extended exam of the back part of the eye with retinal drawing 15 $19 $106
Visual field test, extended 12 $50 $266
Optic nerve imaging (OCT scan) 11 $27 $157
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$29,085
Total received (2018-2024)
Avg $4,155/year across 7 years
Top 12% in FL for neurology
80
Companies
1,313
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,107 (86.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,688 (12.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$290 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,387
2023
$5,542
2022
$4,267
2021
$3,039
2020
$2,190
2019
$2,276
2018
$2,384

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$5,122
Teva Pharmaceuticals USA, Inc.
$2,355
ABBVIE INC.
$1,569
GENZYME CORPORATION
$1,410
Amgen Inc.
$1,111
Alexion Pharmaceuticals, Inc.
$1,111
EMD Serono, Inc.
$935
Neurocrine Biosciences, Inc.
$883
ANI Pharmaceuticals, Inc.
$821
Sunovion Pharmaceuticals Inc.
$771
ARGENX US, INC.
$697
Horizon Therapeutics plc
$635
Grifols USA, LLC
$619
CSL Behring
$580
Lilly USA, LLC
$564
JAZZ PHARMACEUTICALS INC.
$520
PFIZER INC.
$488
Eisai Inc.
$485
Novartis Pharmaceuticals Corporation
$479
Biogen, Inc.
$389
SK Life Science, Inc.
$352
CATALYST PHARMACEUTICALS, INC.
$345
Janssen Pharmaceuticals, Inc
$333
Allergan, Inc.
$321
Biohaven Pharmaceuticals, Inc.
$317
Otsuka America Pharmaceutical, Inc.
$301
Mallinckrodt Hospital Products Inc.
$278
EISAI INC.
$274
Nevro Corp.
$267
Acorda Therapeutics, Inc
$253
Neurelis, Inc.
$252
Supernus Pharmaceuticals, Inc.
$228
Allergan Inc.
$222
MITSUBISHI TANABE PHARMA AMERICA, INC.
$211
Alnylam Pharmaceuticals Inc.
$194
Avion Pharmaceuticals
$193
Catalyst Pharmaceuticals, Inc.
$187
Biohaven Pharmaceutical Holding Company Ltd.
$182
Greenwich Biosciences, Inc.
$170
Takeda Pharmaceuticals U.S.A., Inc.
$162
SCILEX PHARMACEUTICALS INC.
$153
AstraZeneca Pharmaceuticals LP
$144
Amneal Pharmaceuticals LLC
$142
AbbVie Inc.
$133
Avanir Pharmaceuticals, Inc.
$129
GlaxoSmithKline, LLC.
$125
Mitsubishi Tanabe Pharma America, Inc.
$102
Adamas Pharmaceuticals, Inc.
$102
Celgene Corporation
$100
Merz Pharmaceuticals, LLC
$93
LivaNova USA, Inc.
$87
UPSHER-SMITH LABORATORIES LLC
$86
ACADIA Pharmaceuticals Inc
$79
Sumitomo Pharma America, Inc.
$78
Genentech USA, Inc.
$71
Octapharma USA, Inc.
$67
Abbott Laboratories
$64
Xeris Pharmaceuticals, Inc.
$61
Kyowa Kirin, Inc.
$59
Zyla Life Sciences
$59
Lundbeck LLC
$55
Ceribell, Inc.
$52
Upsher-Smith Laboratories LLC
$50
MDD US Operations, LLC
$45
Mallinckrodt LLC
$42
Akcea Therapeutics, Inc.
$41
Bayer HealthCare Pharmaceuticals Inc.
$34
US WorldMeds, LLC
$32
E.R. Squibb & Sons, L.L.C.
$28
Cala Health, Inc.
$22
Vanda Pharmaceuticals Inc.
$20
Merz North America, Inc.
$20
IMPEL PHARMACEUTICALS INC.
$18
Vertical Pharmaceuticals, LLC
$16
Boston Scientific Corporation
$16
Aprecia Pharmaceuticals, LLC
$15
InSightec,Inc
$15
Scilex Pharmaceuticals Inc.
$14
Jazz Pharmaceuticals Inc.
$14
Currax Pharmaceuticals LLC
$11
Top 3 companies account for 31.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AGAMREE · AIMOVIG · AIRSUPRA · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · APTIOM · AREXVY · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · CALA TRIO · COMIRNATY · CONTRAVE · COPAXONE · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · Exablate · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GIVLAARI · GOCOVRI · GVOKE PFS · Gamunex-C · General - DBS · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LEQEMBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · Omnia · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Senza · Soliris · Spritam · TEGSEDI · TEPEZZA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xembify · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,312 per 100 Medicare services performed
Looking for a neurology specialist in Plantation?
Compare neurologists in the Plantation area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
298
Per 100K population
15.3
County median income
$74,534
Nearest hospital
WESTSIDE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gopalaswamy is a clinical cardiology specialist, with above-average Medicare volume (top 26% in FL), with low-engagement industry engagement in the top 12% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gopalaswamy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gopalaswamy performed 389 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gopalaswamy receive payments from pharmaceutical companies?
Yes. Dr. Gopalaswamy received a total of $29,085 from 80 companies across 1,313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gopalaswamy's costs compare to other neurologists in Plantation?
Dr. Gopalaswamy's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gopalaswamy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →